Dublin, Aug. 02, 2023 (GLOBE NEWSWIRE) -- The "Venous Thromboembolism (VTE) Epidemiology Analysis and Forecast to 2032" report has been added to ResearchAndMarkets.com's offering. Epidemiologists ...

Incidence of venous thromboembolism remains 'substantial' despite expert guidelines and newer risk prediction scores ...

Stakeholders concurred that the occurrence of VTE events is a significant public health concern. According to Ralph J. Riello III, PharmD, “It is a problem often that hospitals do not know that they ...

New York, July 21, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Venous Thromboembolism (VTE) Epidemiology Analysis and Forecast to ...

Annual costs of VTE in the United States are substantial and have previously been estimated to be as high as $69.3 billion. 6,7 A study by Mahan et al in 2012 was performed to assess annual US ...

Venous thromboembolism (VTE) frequently complicates cancer. Data on tumour-specific VTE predictors are limited, but may inform strategies to prevent thrombosis. Throughout the follow-up, VTE IR was ...

Abbreviations: VTE, venous thromboembolism; AL, acute leukemia; AML, acute myeloid leukemia; ALL, acute lymphoblastic leukemia; APL, acute promyelocytic leukemia. VTE ...

Patients with cancer are increasingly at risk for venous thromboembolism (VTE). Rates of VTE, however, vary markedly among patients with cancer. This review focuses on recent data derived from ...

Patients with atopic dermatitis (AD) appear to be at increased risk of venous thromboembolism (VTE). That's the key finding in a systemic review and meta-analysis published in the Journal of ...

Science Progress (1933-) Vol. 104, No. 2, 2021 Rivaroxaban for cancer-associated venous thromboembolism This is the metadata section. Skip to content viewer section. All cancers can increase the risk ...